Race Oncology (ASX:RAC) has announced the appointment of experienced biotechnology executive Dr Megan Baldwin to its board as an independent non-executive director.
Latest News
New Stories
-
Race Oncology appoints Opthea founder to its board
December 19, 2024 - - Latest News -
Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’
December 19, 2024 - - Latest News -
Cartherics secures G-Rex grant to support its ‘in house’ manufacturing program
December 19, 2024 - - Latest News -
If you have ovarian cancer, genomic testing may open up new treatment option
December 19, 2024 - - Latest News -
Call for member contributions to April 2025 edition of Australasian Biotechnology Journal
December 17, 2024 - - AusBiotech -
Blood test could make cancer treatments safer and more effective
December 17, 2024 - - Latest News -
Immutep and Monash announce first publication detailing how human LAG-3 Binds to MHC Class II
December 17, 2024 - - Latest News